Prevention of venous thromboembolism in gynecologic oncology surgery

Clarke-Pearson, 1984, The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients, Am. J. Obstet. Gynecol., 148, 1051, 10.1016/0002-9378(84)90632-X Agnelli, 2006, A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project, Ann. Surg., 243, 89, 10.1097/01.sla.0000193959.44677.48 Zhan, 2003, Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization, JAMA, 290, 1868, 10.1001/jama.290.14.1868 The Joint Commission Gunderson, 2014, The survival detriment of venous thromboembolism with epithelial ovarian cancer, Gynecol. Oncol., 134, 73, 10.1016/j.ygyno.2014.04.046 Rauh-Hain, 2015, Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer, Obstet. Gynecol., 125, 1362, 10.1097/AOG.0000000000000866 Barber, 2016, The limited utility of currently available venous thromboembolism risk assessment tools in gynecological oncology patients, Am. J. Obstet. Gynecol., 10.1016/j.ajog.2016.04.034 Martino, 2006, Pulmonary embolism after major abdominal surgery in gynecologic oncology, Obstet. Gynecol., 107, 666, 10.1097/01.AOG.0000200046.28199.ae Clarke-Pearson, 1987, Variables associated with postoperative deep venous thrombosis: a prospective study of 411 gynecology patients and creation of a prognostic model, Obstet. Gynecol., 69, 146 Gould, 2012, Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 141, e227S Gangireddy, 2007, Risk factors and clinical impact of postoperative symptomatic venous thromboembolism, J. Vasc. Surg., 45, 335, 10.1016/j.jvs.2006.10.034 Caprini, 2005, Thrombosis risk assessment as a guide to quality patient care, Dis. Mon., 51, 70, 10.1016/j.disamonth.2005.02.003 Bahl, 2010, A validation study of a retrospective venous thromboembolism risk scoring method, Ann. Surg., 251, 344, 10.1097/SLA.0b013e3181b7fca6 Pannucci, 2011, Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients, J. Am. Coll. Surg., 212, 105, 10.1016/j.jamcollsurg.2010.08.018 Obi, 2015, Validation of the Caprini venous thromboembolism risk assessment model in critically ill surgical patients, JAMA Surg., 150, 941, 10.1001/jamasurg.2015.1841 Stroud, 2014, Validation of a venous thromboembolism risk assessment model in gynecologic oncology, Gynecol. Oncol., 134, 160, 10.1016/j.ygyno.2014.04.051 Corr, 2015, Effectiveness and safety of expanded perioperative thromboprophylaxis in complex gynecologic surgery, Gynecol. Oncol., 138, 501, 10.1016/j.ygyno.2015.07.017 Rogers, 2007, Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study, J. Am. Coll. Surg., 204, 1211, 10.1016/j.jamcollsurg.2007.02.072 Sachdeva, 2014, Graduated compression stockings for prevention of deep vein thrombosis, Cochrane Database Syst. Rev., 12, 10.1002/14651858.CD001484.pub3 Byrne, 2001, Deep vein thrombosis prophylaxis: the effectiveness and implications of using below-knee or thigh-length graduated compression stockings, Heart Lung, 30, 277, 10.1067/mhl.2001.116009 Agu, 1999, Graduated compression stockings in the prevention of venous thromboembolism, Br. J. Surg., 86, 992, 10.1046/j.1365-2168.1999.01195.x Clarke-Pearson, 1993, A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery, Am. J. Obstet. Gynecol., 168, 1146, 10.1016/0002-9378(93)90360-U Maxwell, 2001, Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial, Obstet. Gynecol., 98, 989 Ginzburg, 2003, Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma, Br. J. Surg., 90, 1338, 10.1002/bjs.4309 Clarke-Pearson, 1984, Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy, Obstet. Gynecol., 63, 92 Brady, 2015, Sequential compression device compliance in postoperative obstetrics and gynecology patients, Obstet. Gynecol., 125, 19, 10.1097/AOG.0000000000000554 Clagett, 1988, Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis, Ann. Surg., 208, 227, 10.1097/00000658-198808000-00016 Collins, 1988, Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery, N. Engl. J. Med., 318, 1162, 10.1056/NEJM198805053181805 Ballard, 1973, Low doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynaecological surgery, J. Obstet. Gynaecol. Br. Commonw., 80, 469, 10.1111/j.1471-0528.1973.tb15963.x Clarke-Pearson, 1983, Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin, Am. J. Obstet. Gynecol., 145, 606, 10.1016/0002-9378(83)91205-X Clark-Pearson, 1990, A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis, Obstet. Gynecol., 75, 684 Linkins, 2012, Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 141, e495S Smythe, 2007, The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital, Chest, 131, 1644, 10.1378/chest.06-2109 Warkentin, 2007, Who is (still) getting HIT?, Chest, 131, 1620, 10.1378/chest.07-0425 Holzheimer, 2004, Prophylaxis of thrombosis with low-molecular-weight heparin (LMWH), Eur. J. Med. Res., 9, 150 Mismetti, 2001, Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery, Br. J. Surg., 88, 913, 10.1046/j.0007-1323.2001.01800.x Morimoto, 2014, Perioperative venous thromboembolism in patients with gynecological malignancies: a lesson from four years of recent clinical experience, Anticancer Res., 34, 3589 Kakkar, 1985, Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: a co-operative study, Br. J. Surg., 72, 786, 10.1002/bjs.1800721006 Cyrkowicz, 2002, Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of low molecular weight heparin. Gynecological ward retrospective analysis, Eur. J. Obstet. Gynecol. Reprod. Biol., 100, 223, 10.1016/S0301-2115(01)00482-1 Mismetti, 2012, Venous thromboembolism prevention with fondaparinux 1.5mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study, Thromb. Haemost., 107, 1151, 10.1160/TH11-09-0640 Turpie, 2002, Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies, Arch. Intern. Med., 162, 1833, 10.1001/archinte.162.16.1833 Agnelli, 2005, Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery, Br. J. Surg., 92, 1212, 10.1002/bjs.5154 Eriksson, 2007, Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial, J. Thromb. Haemost., 5, 2178, 10.1111/j.1538-7836.2007.02748.x Wolowacz, 2009, Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis, Thromb. Haemost., 101, 77, 10.1160/TH08-07-0493 Kakkos, 2008, Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients, Cochrane Database Syst. Rev., 10.1002/14651858.CD005258.pub2 Einstein, 2008, A protocol of dual prophylaxis for venous thromboembolism prevention in gynecologic cancer patients, Obstet. Gynecol., 112, 1091, 10.1097/AOG.0b013e31818b1486 Dainty, 2004, Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery, Gynecol. Oncol., 93, 366, 10.1016/j.ygyno.2004.02.004 Kakkar, 1969, Natural history of postoperative deep-vein thrombosis, Lancet, 2, 230, 10.1016/S0140-6736(69)90002-6 Martino, 2012, Preoperative enoxaparin is safe to use in major gynecologic surgery for prophylaxis of venous thromboembolism: a retrospective cohort study, Int. J. Gynecol. Cancer, 22, 681, 10.1097/IGC.0b013e3182454499 Selby, 2016, Preoperative chemoprophylaxis is safe in major oncology operations and effective at preventing venous thromboembolism, J. Am. Coll. Surg., 222, 129, 10.1016/j.jamcollsurg.2015.11.011 Raskob, 2003, Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery, Chest, 124, 379S, 10.1378/chest.124.6_suppl.379S Barber, 2016, Venous thromboembolism in minimally invasive compared with open hysterectomy for endometrial cancer, Obstet. Gynecol., 128, 121, 10.1097/AOG.0000000000001492 Bergqvist, 2002, Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer, N. Engl. J. Med., 346, 975, 10.1056/NEJMoa012385 Wright, 2016, Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery, Gynecol. Oncol., 141, 531, 10.1016/j.ygyno.2016.03.023 Schmeler, 2013, Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies, Gynecol. Oncol., 128, 204, 10.1016/j.ygyno.2012.11.027 Bouchard-Fortier, 2014, Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?, Gynecol. Oncol., 134, 228, 10.1016/j.ygyno.2014.05.012 Nick, 2010, Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery, Obstet. Gynecol., 116, 956, 10.1097/AOG.0b013e3181f240f7 Ritch, 2011, Venous thromboembolism and use of prophylaxis among women undergoing laparoscopic hysterectomy, Obstet. Gynecol., 117, 1367, 10.1097/AOG.0b013e31821bdd16 Sandadi, 2012, Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer, Obstet. Gynecol., 120, 1077, 10.1097/AOG.0b013e31826c31fb Kumar, 2013, Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: a multi-institutional study, Gynecol. Oncol., 130, 207, 10.1016/j.ygyno.2013.04.024 Barber, 2015, Risk of venous thromboembolism in abdominal versus minimally invasive hysterectomy for benign conditions, Am. J. Obstet. Gynecol., 212, e1 Scholten, 2002, A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery, Obes. Surg., 12, 19, 10.1381/096089202321144522 Wang, 2014, Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients, Thromb. Haemost., 111, 88, 10.1160/TH13-01-0042 Guyatt, 2012, Executive summary: antithrombotic therapy and prevention of thrombosis, 141, 7S Baadh, 2012, Indications for inferior vena cava filter placement: do physicians comply with guidelines?, J. Vasc. Interv. Radiol., 23, 989, 10.1016/j.jvir.2012.04.017 Sing, 2013, Inferior vena cava filters: indications and management, Curr. Opin. Cardiol., 28, 625, 10.1097/HCO.0b013e3283655b97 Decousus, 1998, A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group, N. Engl. J. Med., 338, 409, 10.1056/NEJM199802123380701 Group PS, 2005, Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study, Circulation, 112, 416, 10.1161/CIRCULATIONAHA.104.512834 Arous, 2016, Temporary inferior vena cava filters: how do we move forward?, Chest, 149, 1143, 10.1016/j.chest.2016.03.015